(Q38015268)

27 August 2017

title

Concise review: the role of hematopoietic stem cell transplantation in the treatment of acute myeloid leukemia (English)

1 reference

stem cell transplantation

27 August 2017

1 reference

1 reference

Betty K Hamilton

1

1 reference

27 August 2017

Edward A Copelan

series ordinal

2

1 reference

27 August 2017

publication date

1 August 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

8

1 reference

27 August 2017

page(s)

1581-1586

1 reference

The EBMT activity survey 2009: trends over the past 5 years.

27 August 2017

cites work

1 reference

Hematopoietic stem-cell transplantation

21 January 2018

1 reference

Reduced mortality after allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

Tumour stem cells and drug resistance

21 January 2018

1 reference

A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia

21 January 2018

1 reference

Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing

21 January 2018

1 reference

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

21 January 2018

1 reference

CD8(+) minor histocompatibility antigen-specific cytotoxic T lymphocyte clones eliminate human acute myeloid leukemia stem cells

21 January 2018

1 reference

Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences

21 January 2018

1 reference

The hematopoietic cell transplantation comorbidity index (HCT-CI) predicts clinical outcomes in lymphoma and myeloma patients after reduced-intensity or non-myeloablative allogeneic stem cell transplantation.

21 January 2018

1 reference

Hematopoietic stem cell transplantation in adults with acute myeloid leukemia

21 January 2018

1 reference

Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials

21 January 2018

1 reference

Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study

21 January 2018

1 reference

Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study

21 January 2018

1 reference

Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in young and middle-aged adults: benefits for whom?

21 January 2018

1 reference

Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis

21 January 2018

1 reference

Prognostic impact of monosomal karyotype in young adult and elderly acute myeloid leukemia: the Southwest Oncology Group (SWOG) experience

21 January 2018

1 reference

Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation

21 January 2018

1 reference

The presence of a FLT3 internal tandem duplication in patients with acute myeloid leukemia (AML) adds important prognostic information to cytogenetic risk group and response to the first cycle of chemotherapy: analysis of 854 patients from the Unite

21 January 2018

1 reference

Structural and functional alterations of FLT3 in acute myeloid leukemia

21 January 2018

1 reference

Prevalence and prognostic impact of NPM1 mutations in 1485 adult patients with acute myeloid leukemia (AML).

21 January 2018

1 reference

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

IDH1 and IDH2 mutations are frequent genetic alterations in acute myeloid leukemia and confer adverse prognosis in cytogenetically normal acute myeloid leukemia with NPM1 mutation without FLT3 internal tandem duplication

21 January 2018

1 reference

DNMT3A Mutations in Acute Myeloid Leukemia

21 January 2018

1 reference

Prognostic relevance of integrated genetic profiling in acute myeloid leukemia

21 January 2018

1 reference

Integrative prognostic risk score in acute myeloid leukemia with normal karyotype

21 January 2018

1 reference

Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML

21 January 2018

1 reference

Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematol

21 January 2018

1 reference

Impact of cytogenetics on outcome of de novo and therapy-related AML and MDS after allogeneic transplantation

21 January 2018

1 reference

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

21 January 2018

1 reference

Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia

21 January 2018

1 reference

Long-term outcomes after transplantation of HLA-identical related G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow

21 January 2018

1 reference

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

21 January 2018

1 reference

Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia

21 January 2018

1 reference

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

21 January 2018

1 reference

Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia

21 January 2018

1 reference

Effect of graft source on unrelated donor haemopoietic stem-cell transplantation in adults with acute leukaemia: a retrospective analysis

21 January 2018

1 reference

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

21 January 2018

1 reference

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

21 January 2018

1 reference

HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide

21 January 2018

1 reference

Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies

21 January 2018

1 reference

21 January 2018

1 reference

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

21 January 2018

1 reference

Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461.

21 January 2018

1 reference

Reduced-intensity allogeneic hematopoietic transplantation should be considered a standard of care for older patients with acute myeloid leukemia

21 January 2018

1 reference

Loss of mismatched HLA in leukemia after stem-cell transplantation.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/STEM.1140

1 reference

27 August 2017

1 reference